Gene mutations linked to lung cancer found

Researchers in China and the United States have identified mutations of two genes which appear to make ethnic Chinese more susceptible to lung cancer, they wrote in the journal Cancer.

Genome fanatics to post own DNA sequences on Web

A group of scientists and researchers fascinated with the human genome said Monday they will post online their most private personal information - their medical records and DNA sequence of some of their own genes - all for the sake of research.

Genome fanatics to post own DNA sequences on Web

A group of scientists and researchers fascinated with the human genome said Monday they will post online their most private personal information -- their medical records and DNA sequence of some of their own genes -- all for the sake of research.

Genome fanatics share their DNA sequences

A group of scientists and researchers fascinated with the human genome said Monday they will post online their most private personal information — their medical records and DNA sequence of some of their own genes — all for the sake of research.

Scientists Identify Genetic Contributor to Colorectal Cancer Risk (American Cancer Society)

American Cancer Society - Researchers at Ohio State University Comprehensive Cancer Center and Northwestern University's Cancer Genetics Program have found a definitive link between an inherited genetic variation and colorectal cancer risk. The variation, which occurs on a gene known as TGFBR1, significantly increases a person's lifetime risk of getting the disease.

Promising New Tool to Monitor Lung Cancer Treatment Progress (American Cancer Society)

American Cancer Society - Researchers at Massachusetts General Hospital (MGH) are testing a non-surgical technique that may help doctors monitor how well non-small cell lung cancer patients are responding to treatment. Using a device known as a CTC-chip to analyze circulating tumor cells from patients' blood samples, the scientists were able to identify whether patients had genetic mutations that would make them less likely to respond to certain therapies.